UPNT Research Institute, LLC

Arlington, Texas 76017

2 studies enrolling now · 2 studies all time

What they study most

High-Risk Non-Muscle-Invasive Bladder Cancer, Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma

Studies at this site

• A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer — Recruiting now
• Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC — Recruiting now